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Analysis of periprocedural medical complications during
carotid angioplasty and stent placement
İsmail Aydın ERDEN1, Almıla Gülsün PAMUK1, İbrahim Özkan ÖNAL1, Burcu AKBAY ÖZKAYA1,
Seda Banu AKINCI1, Kıvılcım YAVUZ2, Bilge ÇELEBİOĞLU1, Ülkü AYPAR1

Aim: To evaluate periprocedural medical complications during carotid angioplasty and stent placement.
Materials and methods: Data of all patients who underwent carotid artery stenting and were admitted to the
postanesthesia care unit between January and December 2006 were retrospectively evaluated. All patients received
conscious sedation, constant monitoring, and 0.5 mg atropine before balloon inflation. Risk factors and intra- and
postprocedural complications were recorded.
Results: Twenty-two patients were treated for asymptomatic carotid stenosis and 25 patients for symptomatic carotid
stenosis. Of the symptomatic patients 3 presented with retinal symptoms, 15 with a hemispheric transient ischemic attack,
and 7 with a minor stroke. During the procedure 19.1% patients had complications and during Postanesthesia Care Unit
stay 45% had complications. None of the patients had a urinary tract or chest infection or developed symptoms of a
hyperperfusion syndrome. In the 30-day postprocedural follow-up, one patient died due to pulmonary
thromboembolism.
Conclusion: Our results suggest that the overall incidence of complications after carotid artery stent placement was high.
Therefore, patients with higher preoperative risk factors should be monitored closely.
Key words: Carotid artery, angioplasty, stenting, complications, anesthesia

Karotis anjiyoplasti ve stent yerleştirilmesinin periprosedüral döneminde medikal
komplikasyonların analizi
Amaç: Bu retrospektif çalışmanın amacı karotis anjiyoplasti ve stent yerleştirilmesi sırasında gelişen tıbbi
komplikasyonların değerlendirilmesidir.
Yöntem ve gereç: Ocak-Aralık 2006 tarihleri arasında karotis arter stentlenmesi işlemi geçirerek anestezi sonrası yoğun
bakıma kabul edilen bütün hastaların verileri değerlendirildi. Bütün hastalara bilinçli sedasyon, sürekli monitörizasyon
ve balon şişirilmeden önce 0,5 mg atropin uygulandı. Risk faktörleri, işlem sırası ve sonrası komplikasyonlar kaydedildi.
Bulgular: Yirmi iki hasta asemptomatik, 25 hasta ise semptomatik karotis stenozu için tedavi edildi. Semptomatik
hastalardan 3 tanesi retinal semptomlarla, 15 tanesi hemisferik transient iskemik atak ile, 7 tanesi ise minör inme ile
başvurmuştu. İşlem sırasında hastaların % 19,1’inde, Anestezi sonrası yoğun bakım izlemi sırasında ise hastaların %
45’inde komplikasyon izlendi. Hiçbir hastada idrar yolu veya akciğer enfeksiyonu görülmedi ve hiç hiperperfüzyon
sendromu izlenmedi. 30 günlük işlem sonrası izlem sırasında bir hasta pulmoner tromboembolizm ile kaybedildi.
Sonuç: Bizim sonuçlarımıza göre, karotis anjioplasti ve stent yerleştirilmesi sonrası komplikasyon oranları yüksektir. Bu
nedenle, preoperatif risk faktörleri yüksek olan hastalar yakın monitörize edilmelidir.
Anahtar sözcükler: Karotis arter, anjiyoplasti, stentleme, komplikasyonlar, anestezi
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Introduction
Carotid artery stent (CAS) placement is an
investigational technique for carotid artery
revascularization, and reports suggest that this
procedure has promising short- and intermediateterm results (1). There has been growing interest in
and application of carotid artery stenting (2).
Moreover, CAS has emerged as a potential therapeutic
alternative to carotid endarterectomy (CEA) for the
treatment of severe symptomatic or asymptomatic
carotid stenosis. In several case series and trials it is
suggested that CAS can be performed with acceptable
procedure-related neurologic complication rates
compared with CEA (3,4).
To date, most investigators have examined
neurologic complications. Aside from the frequency
of neurologic deficits, the benefit of either CEA or
CAS is also highly dependent on the risk of medical
complications such as myocardial infarction or
hemodynamic complications. In Gröschel et al.’s study
the medical complication rate was 15% (5). Although
most of these nonneurologic complications resolved
completely, some patients had life-threatening or
serious cardiovascular disorders. Hemodynamic
instability, most likely due to stretching of the carotid
sinus and manipulation in the vicinity of the
adventitial baroreceptors, occurs frequently after CAS
and has been shown to correlate with increased
hospital complications and long-term risk of death (610).
All these data enhance the importance of
identification of potential risk factors for medical
complications after CAS, and will become a key
feature for future patient selection and patient
counseling. Therefore, we evaluated periprocedural
medical complications during carotid angioplasty and
stent placement.
Materials and methods
Patient population: We retrospectively reviewed
the database of all patients who underwent CAS and
were admitted to the Postanesthesia Care Unit after
the procedure at our institution from January 2006 to
December 2006. Institutional Review Board approval
was obtained before the study. It is the policy of our
hospital that all patients with a symptomatic or
740

asymptomatic carotid stenosis receive identical and
standardized medical as well as neurologic
evaluations. In all patients the diagnosis of carotid
artery stenosis was made by carotid duplex ultrasound
scanning and/or CT-MR angiography.
Medical treatment: The routine antiplatelet
therapy with clopidogrel and acetyl salicylic acid was
initiated before the procedure. Clopidogrel was
continued for 6 weeks and aspirin given indefinitely.
Carotid angioplasty and stenting procedure: All
procedures were performed with the patient under
conscious sedation with continuous control of heart
rate, blood pressure, and SpO2. For the sedation
midazolam 0.05 mg/kg was administered
intravenously. The sedation levels of the patients were
assessed by the Ramsay sedation scores. A score of 2
or 3 was targeted. When the drug doses were not
enough to reach targeted sedation scores, midazolam
(0.02 mg/kg iv) was repeated. Before balloon inflation,
0.5 mg atropine was administered intravenously in
each patient as a prophylaxis against potential reflex
bradycardia or asystole. All patients received oxygen
by a nasal cannula (5 L/min) to reach at least 95%
oxygen saturation. Procedures started with a
diagnostic angiogram of the aortic arch followed by
selective catheterization of aortic arch vessels in
double projection. In all patients, self-expandable
stents and filter-type embolic protection devices were
used during the CAS procedures. At the end of the
procedure the arterial puncture site was closed by an
Angio-seal vascular closure device (Opakim, ST.
JUDE MEDICAL).
After the stent procedure, all patients were
transferred to the Postanesthesia Care Unit for
overnight observation. Heart rate and oxygen
saturation were monitored continuously and 2
electrocardiograms
(ECG)
were
obtained
immediately after CAS and on day 1. Noninvasive
blood pressure monitoring was performed every 5
min until the end of the procedure. Cardiac enzymes
were routinely collected from every patient. A
physician evaluated any episode of neurologic change.
Postprocedural symptomatic hypotension was treated
with an intravenous infusion of dopamine or
ephedrine, postprocedural hypertension was usually
treated with intravenous esmolol, and symptomatic
sinus bradycardia was treated with intravenous
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atropine. Patients with asymptomatic hypotension
were advised to have bed rest and receive intravenous
fluids or both as a prophylactic measure.
Data collection: All patients’ data were collected
from a database retrospectively including
preprocedural, intraprocedural, and follow-up
information.
Patients with symptomatic internal carotid artery
stenosis were recorded. A carotid stenosis that had not
caused any stroke or TIA in the previous 6 months
was considered asymptomatic. The following
cerebrovascular risk factors were recorded in all
patients:
hypertension,
diabetes
mellitus,
hyperlipidemia, smoking, coronary artery disease,
previous myocardial infarction, history of previous
coronary bypass surgery, and cardiac failure.
Hypertension was defined as occurring when systolic
blood pressure was ≥140 mmHg, diastolic blood
pressure was ≥90 mmHg, or antihypertensive drugs
were used. Diabetes was defined as previously
diagnosed insulin-dependent or non-insulin
dependent diabetes mellitus, and hyperlipidemia as
cholesterol levels 220 mg/dL or in the presence of
lipid-lowering drugs.
The following medical complications during CAS
were recorded: symptomatic hypertension (symptoms
due to systolic blood pressure ≥180 mmHg or
diastolic blood pressure ≥100 mmHg requiring
intravenous medication), symptomatic hypotension
not associated with bleeding or cardiac failure
(symptoms due to systolic blood pressure ≤90 mmHg
requiring administration of vasopressor agent), and
bradycardia (persisting mean heart rate < 50
beats/min). After CAS, myocardial ischemia as
determined by ECG and cardiac enzymes, cardiac
arrhythmias that required antiarrhythmic medication
or a pacemaker, congestive heart failure, angina
pectoris, symptomatic hypertension, symptomatic
hypotension not associated with bleeding or cardiac
failure, renal failure (doubling of preinterventional
urea and/or creatinine), and also access-site related
complications were recorded.
Statistical analysis: Continuous values are
expressed as mean ± SD and nominal variables as
counts and percentages. All statistical analyses were
performed with SPSS (version 11.5) (SPSS, Inc,
Chicago, IL, USA).

Results
The study population consists of 47 CAS patients
(34 men, 13 women; mean age 62 ± 10) of which 22
patients (47%) were treated for asymptomatic carotid
stenosis and 25 patients (53%) for symptomatic
carotid stenosis. Of the symptomatic patients, 3 (25%)
had presented with retinal symptoms, 15 (60%) with
a hemispheric TIA, and 7 (28%) with a minor stroke.
The demographic and clinical characteristics of the
patients are shown in Table 1.
Table 2 summarizes the medical complication rates
during the procedure and at the PACU. During the
procedure 9 (19.1%) patients had complications.
Three patients experienced bradycardia with balloon
inflation. Hypotension occurred in 2 patients. Three
patients experienced hypotension and bradycardia at
the same time. Volume expansion or dopamine or
ephedrine doses were titrated to maintain systolic
blood pressure at 90 mmHg. One patient had
hypertension.
During the PACU stay medical complications
occurred in approximately 45% of all patients.
Twenty-one patients had 1 complication and 2
patients had more than 1.
Three patients (6.4%) had cardiac (2 patients MI,
1 patient arrhythmia), 10 patients (21.3%) had
hemodynamic (6 patients hypotension, 4 patients
hypertension), 9 patients (19.2%) had vascular-access
problems (6 patients bleeding, 3 patients hematoma),
and 2 patients (4.3%) had other complications (1
patient urticaria, 1 patient hematuria). None of the
vascular-access complications required surgical
correction. No patients had a urinary tract or chest
infection.
In the 30-day postprocedural follow-up one
patient died due to pulmonary thromboembolism.
First he suffered a subarachnoid hemorrhage and
underwent surgery. Then he had a deep venous
thrombosis and pulmonary thromboembolism and
died.
Neurological complications were not investigated
during the study.
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Table 1. Baseline characteristics of study patients (N = 47).
Demographics
Mean age (years)

62 ± 10

Male

34 (72.3%)

Female

13 (27.7%)

Presenting symptom
Asymptomatic

22 (47%)

Symptomatic

25 (53%)

Retinal symptoms
TIA

3 (25%)
15 (60%)

Previous stroke

7 (28%)

Preoperative risk factors
Hypertension

27 (57.4%)

Diabetes mellitus

11 (23.4%)

Smoking

24 (51.1%)

Coronary artery disease

19 (40.4%)

Hyperlipidemia

12 (25,5%)

Previous myocardial infarction

4 (8.5%)

History of previous coronary artery bypass surgery

8 (17%)

Cardiac failure

4 (8.5%)

Table 2. Intraoperative and postoperative complications.
Complication

Number of patients (%)

Intraoperative
Bradycardia

3 (6.4)

Hypotension

2 (4.3)

Hypertension

1 (2.1)

Bradycardia + Hypotension

3 (6.4)

Postoperative
Cardiac
Myocardial Infarction

2 (4.3)

Arrhythmia

1 (2.1)

Hemodynamic
Hypotension

6 (12.8)

Hypertension

4 (8.5)

Access-site related
Bleeding

6 (12.8)

Hematoma

3 (6.4)

Other
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Urticaria

1 (2.1)

Hematuria

1 (2.1)
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Discussion
In this study, we analyzed our database of patients
to determine the overall incidence of preprocedural
risk factors and intraprocedural and postprocedural
medical complications. In the study by Gröschel et al.
(5) the postprocedural complication rate was 15% of
all patients. In our study this rate was 45%. Even after
access-site related and other complications (such as
urticaria and hematuria) were excluded from analysis,
the medical complication rate was 25%. This may be
due to 2 reasons: first, life-threatening or fatal
nonneurologic events were common in this series;
this result indicates that the overall incidence of
medical complications after CAS was high. Secondly,
preoperative risk factors such as coronary artery
disease, history of previous coronary bypass surgery,
and heart failure were higher in our study population.
Hemodynamic
instability,
in
particular
symptomatic hypotension, was the most frequent
medical complication (12.8%). This complication is
probably mediated through a dysfunction of
adventitial baroreceptors in arterial segments that are
dilated and covered with intravascular stents (10).
Stent insertion likely leads to more prolonged effects
on hemodynamics because the devices provide
continuous tension on the carotid sinus. Our result
was similar to these previous studies.
Dangas et al. (6) observed post-CAS hypotension
in 25 (19%) of 133 patients (11). In the study by
Qureshi et al. (10), transient hypotensive episodes
after CAS occurred in 22.4% of all patients. Compared
with these studies, the lower incidence of hypotensive
episodes in Gröschel et al.’s (5) study (4.9%) could be
because they only included patients who had
symptoms requiring treatment with vasopressor
agents.
Hypertension was less frequent (8.5%) than
hypotension, but in previous studies it occurred in up
to 40% of all CAS patients (10). Another favorable
finding in our study is that no patients developed
typical symptoms of a hyperperfusion syndrome,

which is a very important and potentially lifethreatening complication.
Previous CAS studies reported that intra- and
postprocedural bradycardia occurred in up to 71% of
all CAS patients but this was an uncommon medical
complication in our series (6.4%) (11). In fact, no
patient required treatment with a temporary venous
pacemaker. It is easily perceivable that this finding can
at least partially be attributed to advances in technique
and equipment for CAS, especially the routine use of
self-expanding stents and of atropine during CAS, as
well as the cautious application of balloon
postdilatation.
Two patients (4.3%) in our study developed
nonfatal myocardial infarctions post-CAS, indicating
that this potentially severe medical complication
might occur more frequently than suggested by
several previous CAS series and trials (12,13). This
might be related to the single center nature of our
study and patient profile of our study (high risk
patients for MI: coronary artery disease (40.4%),
previous myocardial infarction (8.5%)). In
conjunction with our findings, 3.4% of all CAS
patients had a non-Q-wave myocardial infarction in
the recently published ‘Stenting and Angioplasty with
Protection in Patients at High Risk for
Endarterectomy’; (SAPPHIRE) trial (4).
Our study had some limitations: it was a
nonrandomized study. This study was a single center
experience, and we should be cautious in extending
these results to other centers. Moreover, we were
unable to perform subgroup analysis because of the
small sample size.
Carotid artery stenting is a technique that is
gaining widespread usage and acceptance in the
world. As with all newly spreading technologies, its
optimal usage and potential dangers are slowly
becoming apparent. Our series suggests that patients
may present with different dangers and problems for
the anesthesiologist. Therefore, patients with higher
preoperative risk factors should be monitored closely.
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